Detalles de la búsqueda
1.
Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.
Cell Commun Signal;
22(1): 129, 2024 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38360687
2.
NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia.
Blood;
134(4): 383-388, 2019 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31186273
3.
A newly identified 45-kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance.
Mol Oncol;
18(2): 415-430, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104968
4.
Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response.
Cells;
12(4)2023 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36831254
5.
Platelets regulate ischemia-induced revascularization and angiogenesis by secretion of growth factor-modulating factors.
Blood Adv;
7(21): 6411-6427, 2023 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37257194
6.
NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis.
Front Oncol;
12: 875117, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35646639
7.
The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib).
Blood;
107(12): 4970-1; author reply 4972, 2006 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16754777
Resultados
1 -
7
de 7
1
Próxima >
>>